Trials / Conditions / Platinum-Resistant Lung Small Cell Carcinoma
Platinum-Resistant Lung Small Cell Carcinoma
3 registered clinical trials studyying Platinum-Resistant Lung Small Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell NCT05353439 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer NCT04607954 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell C NCT03896503 | National Cancer Institute (NCI) | Phase 2 |